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Abstract
Background: The real clinical utility of genetic testing is the prognostic value of genetic factors in the clinical 
outcome of periodontal treatment and the tooth survival. A meta-analysis was undertaken to estimate the effect 
of a susceptible genotype to periodontitis on the clinical outcomes of non-surgical periodontal therapy and the 
tooth survival.
Material and Methods: A systematic search of MEDLINE-Pubmed, Cochrane Library and Scopus was perfor-
med. Additionally, a hand search was done in three journals. No specific language restriction was applied. Two 
reviewers screened independently titles and abstracts or full text copies. Quality assessment of all the included 
studies was held. 
Results: Initial screening of electronic databases resulted in 283 articles. Ten studies met the inclusion criteria, 
nine of them examined the clinical outcome, while the other one investigated the tooth survival in susceptible 
individuals after non-surgical periodontal therapy. Eight of included studies were selected for the meta-analysis. 
IL-1 positive genotypes increase the risk of tooth loss, while no association found between the bleeding on pro-
bing (BOP), clinical attachment loss (CAL) and plaque index (PI) with the genotype status. Probing pocket depth 
(PPD) reduction in the first three months and in long-term results found to have a significant association with the 
genotype.
Conclusions: There is no difference in the clinical measurements after non-surgical periodontal treatment, apart 
from PPD. More publications are needed to identify a cause-effect relationship.
Key words: Periodontal disease, periodontitis, periodontal therapy, clinical outcome, tooth loss, susceptibility, 
polymorphism, genotype, meta-analysis, systematic review.
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Introduction
Periodontal disease is commonly defined as a chronic 
multifactorial infectious disease where the tissue su-
pporting the teeth is destroyed (1). It was believed that 
the progression of periodontitis is a result of microbial 
and environmental factors. Nowadays there is evidence 
supporting that genetic susceptibility plays a role in the 
onset and progression of periodontitis (2,3). The existen-
ce of high-risk group of patients could not be explained 
by the microbiology alone (4). Approximately 10-15% 
of the population appears to have quickly progression 
from gingivitis to periodontitis (4). As in other complex 
diseases is estimated that 10 to 20 genes are involved in 
the onset and progression of periodontal disease. Ethnic 
populations appear to have different alleles encoding 
the same gene (5). 
The researchers are seeking genetic evidence to explain 
the differences in periodontal disease susceptibility. The 
first evidence that genetics play a role in periodontal di-
sease appeared in the early 1990s. The presence of a ge-
netic risk factor increases the probability of developing 
periodontal disease (6-8). Cytokines as Interleukin-1 
(IL-1), Interleukin-2 (IL-2), Interleukin-4 (IL-4), Inter-
leukin-6 (IL-6), Interleukin-10 (IL-10), Tumor necrosis 
factor (TNF), Transforming growth factor-β1 (TGF-β1), 
cell-surface receptors, chemokines and enzymes are 
proteins translated from different DNA sequences (9). 
All of them play determinant roles in antigen recogni-
tion, immune system and host response (9). 
Gene polymorphisms
IL-1 is a pro-inflammatory cytokine which plays an im-
portant role in chronic inflammation and has been im-
plicated in chronic diseases, such as periodontitis (10). 
A combined genotype with single nucleotide exchanges 
in the IL-1A and IL-1B gene was found to be associated 
with an increased risk of periodontitis (11). 
IL-4 is another inflammatory cytokine which is a potent 
down regulator of macrophage function. Lack of IL-4 in 
periodontal tissues may cause increased CD14 expres-
sion and high production of IL-1B, TNF-a and PGE2 in 
human monocytes with an end result of bone resorption 
(12). Polymorphism in the IL-4 gene has been investiga-
ted and it has been reported that individuals-carriers of 
the TCI/CCI haplotype are more susceptible to chronic 
periodontitis than those who carry the TTD/CTI haplo-
type. The haplotype T(-590)/T(-33)/allele 2 VNTR (70 
base pairs) (2) of the IL-4 gene was significantly more 
frequent in patients with chronic periodontitis (13).
Interleukin-8 is a cytokine which activates the neutro-
phils (14). Studies have found that the SNPs in the IL-8 
gene like -251 (T/A), +396 (T/G), +781 (C/T) were as-
sociated significantly with the presence and severity of 
chronic periodontitis (15,16). 
Matrix metalloproteinases (MMPs) are host and bacte-
rial derived proteinases (17). MMPs play an important 
role in wound healing (18). MMPs degrade different 
proteins of the extracellular matrix, for example diffe-
rent types of collagens. As a result matrix metallopro-
teinases can determine the inflammatory response (17). 
MMP-1 and MMP-13 gene polymorphisms have found 
to influence the levels and the activity of MMPs which 
in turn are associated with the progression of periodon-
tal disease (19). Several polymorphisms have been well 
characterized and recognized an association or not with 
chronic periodontitis (20).
Mannose binding lectin (MBL) is a protein with impor-
tant role in innate immunity. MBL is associated with 
the first line of defense against infection. Many studies 
have found an influence of MBL on various bacterial 
diseases including periodontal disease (21). It has been 
found two types of MBL genes: MBL-1 which is a pseu-
dogene and MBL-2 (22). 
The main purpose of periodontal therapy is the long 
term retention of natural teeth in a healthy environ-
ment. Identifying gene polymorphisms can contribute 
in diagnostics for susceptibility to periodontal disease 
(9). Nowadays, the real clinical utility of genetic testing 
is the prognostic value of genetic factors in the clinical 
outcome of periodontal treatment and the tooth survi-
val. 
The purpose of this paper was to assess the clinical 
outcomes of non-surgical periodontal therapy and the 
tooth survival after non-surgical therapy in patients 
with genetic susceptibility to periodontal disease.
Material and Methods
The systematic review was conducted according to the 
Cochrane handbook for systematic review (23). The 
transparent reporting of systematic reviews and meta-
analyses has been ensured by the use of the PRISMA- 
Statement (24).
* Review questions
- The following questions were addressed:
What is the effect of a susceptible genotype of periodon-
titis following non-surgical periodontal therapy on the 
clinical parameters of periodontal inflammation, such 
as probing pocket depth (PPD) measurements, clinical 
attachment level (CAL) measurements, bleeding on pro-
bing (BOP) score, plaque index (PI), gingival bleeding 
index (GBI) and on the survival of teeth, compared to 
non-susceptible genotypes?
What is the influence of smoking habits on the clinical 
outcomes after non-surgical periodontal therapy in in-
dividuals who are susceptible to periodontitis?
- Literature search
Eleven key terms were used, combined in three search 
strategies. The electronic databases were electronically 
searched using the following search strategy:
1) (periodontal therapy OR clinical outcome OR tooth 
loss)
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2) (periodontal diseases OR periodontitis OR periodon-
tal disease)
3) (polymorphism, genetic OR polymorphism OR geno-
type OR haplotype)
4) 1 AND 2 AND 3.
These sources included the US National Library of Me-
dicine National Institutes of Health (MEDLINE-Pub-
med), the Cochrane Library and Scopus (Database by 
Elsevier). Articles from inception of these databases up 
to the end of March 2014 (week 4) were considered. A 
second search in the same sources was conducted be-
fore the statistical analysis was completed in order to 
make sure that no new articles were published. A com-
plementary manual search up to the same period was 
carried out in the following Journals: Journal of Clinical 
Periodontology, Journal of Periodontology and Journal 
of Periodontal Research.  No specific language restric-
tion was applied to any of the searches, although the 
electronic searches could only identify studies inclu-
ding at least a title in English because the terms were 
in English.
- Study selection
Abstracts were obtained for all the titles identified du-
ring electronic and manual searches. If eligibility as-
pects were present in the title, then the study was re-
ferred for further reading. If none of the aspects were 
present, then the abstract was read in details. Full-text 
copies were obtained for all titles remaining after scree-
ning. Two reviewers screened independently titles and 
abstracts or full text copies to eliminate articles that 
clearly failed to meet the inclusion criteria:
1) Papers written in any language.
2) Studies conducted in humans, aged 18 years and ol-
der, in good general health and diagnosed with chronic 
periodontitis. 
3) Studies investigate the influence of susceptible ge-
notypes of periodontitis on the clinical outcome or on 
the number of tooth loss after non-surgical periodontal 
treatment.
4) Evaluation of the clinical outcome with one or more 
of the clinical parameters: probing pocket depth (PPD), 
clinical attachment level (CAL), bleeding on probing 
scores (BOP), plaque index (PI), gingival bleeding in-
dex (GBI).
5) Evaluation of the tooth loss with the number of teeth 
before and after non-surgical periodontal treatment .
6) Baseline measurements and final measurements of 
clinical parameters at least four (4) weeks after non-
surgical periodontal treatment is needed. 
7) Type of therapy: Non-surgical periodontal treatment 
of scaling and root-planing performed by periodontist/
periodontists. 
Exclusion criteria included surgical periodontal 
treatment and/ or treatment with the use of antibiotics.
In case of disagreement, it was resolved by discussion 
among the two reviewers. The articles that fulfilled the 
above criteria were processed for data extraction. 
- Data extraction
The data from articles that met the inclusion criteria were 
extracted by the two reviewers. The clinical parameters 
that were used to evaluate the periodontal treatment 
outcome were at least one of the PPD, CAL, BOP, PI, 
GBI. The tooth survival was measured by the number of 
teeth pre-treatment and post-treatment. For studies that 
presented more than one outcome assessment, only the 
baseline and the final measurements were used. 
- Quality assessment
The quality assessment of all the included studies in this 
meta-analysis was performed based on the Newcastle–
Ottawa scale (NOS) (25). The modified NOS was used 
as described by Chambrone et al. (26) and assessment 
of selection, comparability, exposure and statistical bias 
were performed. In our study additional changes were 
performed to Chambrone’s modified NOS in order to 
assess the methodological quality of the included stu-
dies. All the methodological quality assessment criteria 
that were utilized in this study are presented in table 1.
- Statistical analysis 
Analyses were performed according to the availability 
of data for each of the outcomes (PPD, CAL, BOP, PI), 
for several post-enrollment time frames. The measure 
effect was thus expressed and presented as standardi-
sed mean difference of the improvement (change) ob-
served within three different time intervals: one mon-
th / 45 days, three months and six months. The main 
analysis, which included all of the studies, was based on 
their long-term results, whereas individual studies were 
grouped according to their maximum follow up period 
(subgroup analysis). Before proceeding to the analyses, 
further calculations were deemed necessary. These in-
cluded the transformation of values expressed in the 
form median (minimum – maximum) into the form of 
mean (standard deviation - SD) (27). Changes in means 
were calculated by subtracting baseline from follow up 
values, within each group of individual studies. SDs of 
the changes in means, were then calculated by using a 
formula, based on the assumption that the correlation 
coefficient [r] between the two measures is equal to 0.5. 
Pooled estimates and 95% confidence intervals were 
calculated by using an inverse variance random-effects 
approach, for each of the outcomes. Re-analysing data 
using a fixed-effects model, yielded similar results. 
Results are presented in the form of forest plots. He-
terogeneity was explored by using the I2 statistic and 
chi-square test. The small number of included studies 
did not allow further assessment of heterogeneity for 
identifying its possible sources. Funnel plots were used 
to detect potential publication bias in regard to the long 
term effects of each study. All analyses were performed 
using the RevMan 5.3 software.
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Results
Initial screening of electronic databases resulted 283 
articles; 206 of them were retrieved from the search of 
Pubmed-MEDLINE, 74 from Scopus-Elsevier and 3 
from Cochrane Library. The screening of titles and abs-
tracts initially resulted 23 articles. Based on inclusion 
and exclusion criteria 13 of them were excluded (Fig. 1). 
The 13 studies were excluded for the following reasons: 
Surgical treatment in some cases and maintenance (28-
35); surgical treatment in some cases and patients ac-
cepted to be <18 years old (36,37); antimicrobial therapy 
with antibiotics (38); periodontal therapy performed by 
hygienist (39); not systematically healthy patients (39); 
sample consisted of patients with aggressive periodonti-
tis (40). Hand searching of the selected journals did not 
reveal any additional publication. 
The final selection included 10 articles (Fig. 1). In 9 of 
these studies the influence of susceptible genotypes of 
Selection 
1) Representativeness of the patients with periodontal disease 
                                     a) truly representative of the average of positive genotyped patients to periodontal disease *  
                                     b) somewhat representative of the average of positive genotyped to periodontal disease *
                                     c) selected group of patients 
                                    d) no description of the derivation of the group 
2) Selection of the positive and negative genotyped patients to periodontal disease  
                                    a) drawn from the same community as the patients with periodontal disease*  
                                    b) drawn from a different source 
                                    c) no description of the derivation of the patients 
                                    d) not included in the study  
3) Ascertainment/assessment of periodontal conditions 
                                   a) adequate (diagnosis based on full mouth probing measurements, i.e. PPD and CAL or full  
                                   mouth radiographic evaluation)* 
                                   b) partial mouth recordings 
                                   c) self-reported 
                                   d) no description 
4) Clear definitions of methods to access genotype profile 
                                   a) yes*   
                                   b) no 
5) Training/calibration of assessors of clinical outcomes  
                                   a) yes* 
                                   b) no 
6) Prospective data collection and description of clear inclusion/exclusion criteria 
                                   a) yes *
                                   b) no 
Comparability
 1) Comparability of groups (patients) on the basis of the design or analysis
                                  a) all patients received the same  non-surgical periodontal treatment *  
                                  b) not all patients received the same non-surgical periodontal treatment 
2) Management of confounders (data collection and investigation of impact) 
                                 a) study/assessment performed with control for confounders*  
                                 b) study/assessment performed without control for cofounders 
Outcome 
1) Assessment of periodontal outcomes  
                              a) independent blind assessment*
                              b) record linkage* 
                              c) self report  
                              d) no description 
2) Adequacy of follow up of patients 
                              a) complete follow up - all subjects accounted for *
                              b) subjects lost to follow up unlikely to introduce bias - small number lost  > 70 %  follow up,  
                              or description provided of those lost) *
                              c) follow up rate < 70 % and/or no description of those lost 
                              d) no statement  
 Statistics 
1) Appropriateness/validity of statistical analysis 
                             a) valid*  
                             b) invalid 
                             c) unclear or not reported 
2) Unit of analysis (response rate) reported in the statistical model 
                             a) number of patients per group*  
                             b) percentage of patients per group 
                             c) unclear or not reported 
Table 1. Quality assessment using the modified Newcastle-Ottawa Scale (NOS).
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periodontitis on the clinical outcome was investigated 
(22,41-48) while one of them examined the number of 
teeth lost after non-surgical periodontal treatment in 
susceptible and non-susceptible patients to chronic pe-
riodontitis (49). We contacted the authors of two studies 
to obtain details for the study sample size and the PPD 
baseline measurements that were performed by the exa-
miners. One author did not reply and the study was ex-
cluded. The other author provided the important details 
and the article included in our study. 
- Study Characteristics
The characteristics of the included studies in the present 
systematic review are presented in tables 2,3.
The year of publication of the selected studies range 
from 2005 to 2013. The sample included patients diag-
nosed with chronic periodontitis. Also, patients with 
healthy periodontal tissues were included in five studies 
in order to meet other objectives (22,41,42,44,45). In 
case of chronic periodontitis, non-surgical periodontal 
treatment with oral hygiene instruction, scaling and 
root planing under local anesthesia, was performed by 
one or more periodontists. The sample was selected 
to be systematically healthy. Patients’ ethnicity varied 
among: European descent, Turkish from Aegean re-
gion, Japanese, White skin colour, Turkish Caucasians, 
Caucasians, Africans/Carribeans and Asians. Measure-
ments were performed at least one month after baseline 
examination in all the included studies.
A wide range of gene polymorphisms was studied and 
Interleukins’ polymorphisms are the most investigated. 
In the included studies of this meta-analysis, the asso-
ciation between IL-1, IL-4, IL-6, IL-8, MMP-1, MMP-
13 and MBL haplotypes and the clinical outcomes was 
investigated. Probing pocket depth (PPD), Clinical atta-
Fig. 1. Study selection.
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chment level (CAL) and Bleeding on probing (BOP) 
were at least measured in the nine articles that studied 
the clinical outcome of non-surgical periodontal thera-
py. McGuire and Nunn (49) measured PPD, presence of 
furcation, mobility, bone loss and the crown to root ra-
tio. The number of subjects in each study ranged from 
15 (42) to 94 patients (47). 
The majority of the included studies consisted of non-
smokers or more than five years former smokers. The 
evaluation of the influence of smoking habits on the 
clinical outcomes of susceptible to chronic periodonti-
tis patients was one of the goals of this meta-analysis. 
The sample size of smokers was extremely, low while 
the lack of data of smokers and the absence of statisti-
cal analysis between the smoking habits and the perio-
dontal therapy outcomes made impossible to conclude 
to a measurable result. Only one study examined this 
parameter. Smokers (9 smokers, 30 history of smoking 
and 3 nonsmokers) were included in the retrospective 
study of McGuire and Nunn (49) and after 14 years of 
the baseline measurements, they concluded that IL-1, 
smoking and the combined effect increase the risk of 
tooth loss. The sample of this study was patients from a 
private practice with a mean age of 46 years and the age 
ranged from 33 to 62 years. IL-1 positive subjects was 
the 38.1% of the total sample. 
Author, Year of 
publication,
Reference 
Study 
design and 
type of 
study 
Source of 
the sample Gene 
Sample 
size 
(SCP/NS
CP)
Periodontal
status Ethnicity 
Smoking
status
Location of the 
polymorphism 
Corbi et al., 
2013, (46) 
Prospective 
cohort 
Patients 
from dental 
school 
IL-8 41 
(21/20) 
Moderate 
and localized 
chronic 
periodontitis 
European 
descent 
Non smokers -251(T/A), 
+396(T/G), 
+781(C/T) 
Pirhan et al., 
2009, (45) 
Prospective 
cohort 
Patients 
from dental 
school 
MMP-13 58 
(24/34) 
Chronic 
Periodontitis 
Turkish 
from Aegean 
region 
Smokersۆ and 
non smokers 
-77A/G 
Pirhan et al., 
2008, (44) 
Prospective 
cohort 
Patients 
from dental 
school 
MMP-1 58 
(30/28) 
Chronic 
Periodontitis 
Turkish 
from Aegean 
region 
Smokersۆ and 
non smokers 
-519A/G, 
-1607 1G/2G 
Yoshie et al., 
2007, (48) 
Prospective 
cohort 
Patients 
from dental 
school 
IL-1 49 
(12/37) 
Chronic 
Periodontitis 
Japanese Non smokers 
38, smokers 11 
IL-1A +4845 
(allele 1, G. allele 2, T) 
Anovazzi et al., 
2013, (41) 
Prospective 
cohort 
Patients 
from dental 
school 
IL-4 26 
(16/10) 
Generalized 
chronic 
periodontitits 
NR Non-smokers or 
former smokers 
>5 years 
-590(T/C, promoter), 
+33(C/T, 5' UTR 
region, 
VNTR(insertion/deletio
n of 70 bp in intron 3) 
Finoti et al., 
2013, (43) 
Prospective 
cohort 
Patients 
from dental 
school 
IL-8 30 
(14/16) 
Chronic 
periodontitis 
NR Non-smokers or 
former smokers 
>5 years 
-251(T/A), 
+396(T/G), 
+781(C/T) 
Finoti et al., 
2013, (42) 
Prospective 
cohort 
Contacted 
by phone 
and treated 
in a dental 
school 
IL-4 15 (6/9) Chronic 
Periodontitis 
White skin 
colour 
Non-smokers or 
former smokers 
>5 years 
–590(C/T) and 
+33(C/T), 
VNTR(insertion/deletio
n of 70 bp in intron 3) 
Ozcaka et al., 
2010, (22) 
Prospective 
cohort 
Patient from 
dental 
school 
MBL 83 
(40/43) 
Chronic 
Periodontitis 
Turkish 
Caucasians 
Non-smokers or 
light smokers 
(<10 cigarretes 
per day for <5 
years) 
codon 54 
D'Aiuto et al., 
2005, (47) 
Prospective 
cohort 
Referrals to 
a dental 
school 
IL-6 94 (NR) Severe 
generalized 
periodontitis 
Caucasians, 
African/Carr
ibean, 
Assian 
Current 
smokers or non-
smokers 
-174 
Table 2. Main characteristics of the included studies of the systematic review investigating the association between the genotype status and 
the clinical outcomes of the non-surgical periodontal therapy.
ǂ smoked less than 10 cigarettes per day for less than 5 years.
 NR: Not Reported 
 SCP: patients with susceptibility to chronic periodontitis (susceptible patients) 
 NSCP: patients with no susceptibility to chronic periodontitis (non-susceptible patients)
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Analyses were stratified according to the clinical pa-
rameters (BOP, PPD, CAL, PI) of the susceptible and 
non-susceptible patients to periodontal disease and the 
time of the follow-up measurements. Results from the 
random effects model are reported. To assess heteroge-
neity, a p-value, derived from Cochran’s Q statistics for 
the null hypothesis was calculated.
All the included studies in this systematic review were 
assessed by the use of the modified NOS regarding the 
study design (selection, comparability, outcome and 
statistics). Bias assessment revealed that all of the in-
cluded studies were of high quality (range from 10 to 
12 points). The scores of the methodological quality 
assessment of the studies selected for this review are 
presented in table 4.
- Baseline up to 30 or 45 days after initial examination
Firstly the analysis was conducted for the studies with a 
follow-up of 30 to 45 days and evaluated the differences 
between the baseline and the 30 or 45 days measure-
ments. The random effects estimate for the mean di-
fference of the BOP scores was -0.03% [95% CI: -0.31, 
0.26], the mean difference of the CAL was 0.04mm 
[95% CI: -0.17, 0.25], the mean difference of the PI sco-
res was -0.05% [95% CI: -0.29, 0.19], while the mean di-
fference of the PPD was -0.09mm [95% CI: -0.29, 0.11]. 
There is no evidence for a significant difference in the 
evaluated parameters when comparing susceptible and 
non-susceptible patients.
- Baseline up to 3 months after initial evaluation
The random effects estimates for the mean differences 
Author, Year 
of publication, 
Reference 
Measurements performed by 
Baseline and 
following  
re-examination 
Measurements Definition of the periodontal classification 
Association between positive 
genotype and outcomes 
Corbi et al., 
2013, (46) 
Single 
calibrated examiner, blinded 
to the genetic status 
Baseline and 45 
days after 
therapy  
PPD, percentage of sites 
with PPD 4 mm, CAL, 
BOP, visible PI, GBI, 
percentage of sites with a 
reduction/increase of at 
least 2 mm in PPD 
Moderate CP when CAL=3 4mm. Severe 
CP when CAL 5 mm. 
No significant differences between 
patients with or without this haplotype 
after therapy.  
Pirhan et al., 
2009, (45) 
Single investigator Baseline, 1 and 6 
months  
PPD, CAL, supragingival 
plaque 
accumulation, BOP 
CP when 15 teeth exhibited 
>30% of measured sites with 5mm CAL. 
BOP at >50% of the proximal sites and 
exhibited alveolar bone loss of 50% in at 
least two different quadrants 
77G allele no influence found for the 
clinical outcome of therapy. 
Pirhan et al., 
2008, (44) 
Single investigator Baseline, 1  and 
6  months 
PPD, CAL, supragingival 
plaque accumulation, BOP 
Severe CP when at least four sites with a  
CAL5mm exhibited in at least two 
separate quadrants. BOP>50% of the sites. 
519G allele carries higher percentage of 
sites 4-6 mm CAL after therapy 
Yoshie et al., 
2007, (48) 
Several calibrated 
periodontists 
Baseline and 4 
weeks after 
therapy 
Number of missing teeth, 
PPD, CAL, BOP 
CP Mean values of CAL, PPD, BOP 
decreased significantly after therapy. 
No significant difference in the clinical 
parameters (carriers - non carriers) 
Anovazzi et al., 
2013, (41) 
single previously calibrated 
examiner blinded to the 
patient‘s 
genetic carriage 
Baseline and 
45,90 days after 
therapy 
PPD, percentage of the 
sites with PPD4 mm, 
CAL, BOP, PI, GI 
CP when two or more sites in non-adjacent 
teeth exhibited 
PPD5 mm, CAL3 mm and BOP 
No association found between 
susceptible haplotype of IL-4 and 
response to periodontal non-surgical 
therapy 
Finoti et al., 
2013, (43) 
single previously calibrated 
examiner 
Baseline and 45 
days after 
therapy 
PPD, CAL, BOP CP when two or more 
sites exhibited PPD 5 mm, CAL  3 mm, 
and BOP. 
No association (Il-8 and treatment 
outcome) 
Finoti et al., 
2013, (42) 
single previously calibrated 
examiner, blinded to the 
patient’s 
genetic carriage 
Baseline and 45, 
90 days after 
therapy 
PPD, CAL, BOP CP No association (IL-4 and treatment 
outcome) 
Ozcaka et al., 
2010, (22) 
single calibrated examiner Baseline and 
1,3,6 months  
PPD, CAL, 
supragingival plaque 
accumulation and BOP 
CP when >30% of measured sites 
with5mm CAL and 
50% alveolar bone loss on at least one 
tooth on at least two different quadrants.  
BOP at >50% of the sites 
MBL gene codon 54 B allele carriage 
may not influence the treatment 
outcome 
D'Aiuto et al., 
2005, (47) 
Masked, calibrated 
examiner 
Baseline and 2,6 
months after 
therapy 
PPD, REC, Plaque control, 
BOP, CAL, tooth mobility, 
furcation,  
Severe generalized periodontitis (PPD5 
mm with BOP and marginal alveolar bone 
loss >30% in at least 50% of the dentition. 
Significantly associated with a smaller 
decrease in the number of pockets 
Table 3. Characteristics of the study design of the included studies of the systematic review investigating the association between the geno-
type status and the clinical outcomes of the non-surgical periodontal therapy.
PPD: Probing pocket depth. BOP: Bleeding on probing. CAL: Clinical attachment loss. PI: Plaque index. GBI: Gingival bleeding index.  CP: 
Chronic periodontitis. GI: Gingival index. REC: Gingival recession.
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between the initial and the 3 months measurements of 
the BOP scores, CAL, PI scores and PPD were 0.12% 
[95% CI: -0.26, 0.50], -0.29mm [95% CI: -0.78, 0.21], 
0.24% [95% CI: -1.03, 1.50] and -0.65mm [95% CI: -1.14, 
0.16] respectively. Measurements of BOP scores and PI 
scores were included in only in two studies (22,41) whi-
le measurements of CAL and PPD were presented in 
three studies (22,41,42) and the meta- analysis could not 
provide a safe result. 
- Baseline up to 6 months after initial evaluation
Four groups of patients from three different studies 
(22,44,45) were re-examined six months after the ini-
tial examination. The meta-analysis did not provide evi-
dence for statistical significance between the SCP and 
NSCP groups in regard to the change from baseline to 
final measurements. The random effects estimates for 
the mean differences between the initial and the 3 mon-
ths measurements of the BOP scores, CAL, PI scores 
and PPD were -2.64% [95% CI: -11.62, 6.34], -0.09mm 
[95% CI: -0.34, 0.15], -0.14% [95% CI: -0.39, 0.11] and 
-0.18mm [95% CI: -0.43, 0.06] respectively. 
- Long term results of the studies with subgroup analy-
sis according to time periods (30-45 days, 3 months and 
9 months)
Results of the meta-analysis did not reveal any systema-
tic significant differences in measure effect that would 
favor a specific genotype profile against another, with 
regard to their response to treatment, for each of the 
BOP, CAL and PI scores. The p-values were calculated 
as 0.33, 0.74 and 0.96 respectively. The mean differen-
ces were estimated using random effects models: -0.14% 
[95% CI: -0.44, 0.15] for BOP, -0.03mm [95% CI: -0.24, 
0.17] for CAL and -0.01% [95% CI: -0.35, 0.34] for PI 
scores. As far as PPD measurements are concerned, the 
p-value was found to be statistically significant, (p= 
0.03), with I2=0% which indicates absence of heteroge-
neity and mean differences of -0.22mm [95% CI: -0.41, 
-0.02]. 
Forest plots of the meta-analyses and funnel plots for as-
sessing the publication bias, considering the long term 
effects of each study, for BOP, CAL, PI and PPD are 
presented in figures 2-5. Funnel plots (treatment effect 
against standard error), based on a visual and thus sub-
jective assessment, look slightly asymmetric towards 
the bottom of the graph, which might be an indication 
of presence of publication bias.
Discussion
Current results do not support the hypothesis that in-
dividuals with a genetic susceptibility to periodontal 
disease would have a worse clinical outcome after non-
surgical periodontal therapy, compared to the non-sus-
ceptible individuals. 
The number of the studies included in this systematic 
SELECTION COMPARABILITY OUTCOME STATISTICS TOTAL 
Author, Year 
of publication, 
Reference 
Q1 Q2 Q3 Q4 Q5 Q6 Q1 Q2 Q1 Q2 Q1 Q2 Totalpoints 
Methodological 
quality
Corbi et al., 
2013, (46) 
* * * * * * * * * * * * 12 High 
Pirhan et al., 
2009, (45) 
* * * *  * * * * * * * 11 High 
Pirhan et al., 
2008, (44) 
* * * *  * * * * * * * 11 High 
Yoshie et al., 
2007, (48) 
* * * * *  * * * * * * 11 High 
Anovazzi et al., 
2013, (41) 
* * * * * * * * * * * * 12 High 
Finoti et al., 
2013, (43) 
* * * * * * * * * * * * 12 High 
Finoti et al., 
2013, (42) 
* * * * * * * * * * * * 12 High 
Ozcaka et al., 
2010, (22) 
* * * * * * * * * * * * 12 High 
D'Aiuto et al., 
2005, (47) 
 * * * * * * * * * *  10 High 
Table 4. Quality assessment of the included studies.
The Newcastle-Ottawa Scale (NOS) was utilized to assess the methodological quality of the included studies. This scale was developed by 
Wells and colleagues (25), and a modified version of this tool was used by Chambrone et al (26). In our study, we included a modification 
of the NOS based on the original and Chambrone’s changes. The selection of study groups, the comparability of subjects, the outcome, 
and the statistical analysis were assessed. A study can be awarded points (stars) for the various criteria. Each study could get 12 points 
in maximum. Studies that received 80% or more of the total number of points were considered being of high quality (10 points). Medium 
quality studies exhibited at least 7 points, and studies with less than 7 points demonstrated low quality.
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review was considered insufficient and inappropriate for 
the extraction of inferences regarding the evaluation of 
the tooth loss after non-surgical therapy, gingival blee-
ding index (GBI) and gingival index (GI). Bleeding on 
probing (BOP), clinical attachment loss (CAL), probing 
pocket depth (PPD) and plaque index (PI) were assessed 
to extract the conclusions.
The sample was limited to periodontal patients with no 
systematic diseases, in order to minimize the factors 
that can influence the periodontal treatment outcome. 
The clinical outcome was evaluated at least four weeks 
after completion of therapy. Concerning the type of the-
rapy, studies with non-surgical periodontal treatment 
were only included. Nonsurgical periodontal treatment 
is the therapy of choice for moderated and advanced 
chronic periodontitis. Surgical treatment or anti-infec-
tive therapy could have influenced the clinical outcome 
and their results could not be compared with those of 
non-surgical treatment.
Based on the presented evidence there is an associa-
tion between the susceptibility to chronic periodontal 
disease and the PPD in the first three months after non-
surgical periodontal treatment and in long-term results. 
The analyses of the available data for each of the outco-
me measurements (BOP, CAL and PI) and for several 
post-intervention time frames (30-45 days, 3 months 
and 6 months) concluded that there is no statistically 
significance between susceptible and non-susceptible 
individuals. The heterogeneity of the included studies 
was found to be minimal and low to moderate.
Fig. 2. The forest plot and the funnel plot of the comparison: long term effects of each study and BOP (%).
Meta-analysis and forest plot comparing susceptible (SCP) and non-susceptible (NSCP) to periodontal disease with the differ-
ence of bleeding on probing score (BOP) long term. Presenting the mean differences of bleeding on probing (BOP) after non-
surgical periodontal therapy in 1 month-45 days, 3 months, 6 months separately and as total. BOP is measured in percentage. 
The funnel plot is designed to check for the existence of publication bias.
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PPD measurements between the baseline and three 
months after periodontal treatment were found to be 
statistically significant (p=0.009). The significance was 
resulted from only three studies with low to moderate 
heterogeneity (I2=28%) and thus the current evidence is 
insufficient to support the initial hypothesis. Long-term 
results of PPD measurements were statistically signifi-
cant (p=0.03) with minimal heterogeneity (I2=0%). 
An association was found between the presence of IL-1 
susceptible genotype and smoking with the risk of tooth 
loss. However, only one study which investigated the 
effectiveness of the periodontal treatment in relation to 
tooth survival was included in this systematic review. 
McGuire and Nunn concluded that in case an IL-1 posi-
tive genotype of a patient is diagnosed, dentists should 
be suspicious for a greater likelihood of tooth loss. In 
this retrospective study, the prognosis of tooth survival 
in IL-1 positive non-smokers was found to be less favo-
rable than in IL-1 negative non-smokers. However, pro-
viding periodontal therapy in combination with suppor-
tive periodontal treatment in IL-1 positive non-smokers 
result in maintaining the teeth for many years (49).
The association between gene polymorphisms in chro-
nic periodontitis and response to treatment was exami-
                         
Fig. 3. The forest plot and the funnel plot of the comparison: long term effects of each study and CAL (mm).
Meta-analysis and forest plot comparing susceptible (SCP) and non-susceptible (NSCP) to periodontal disease with the differ-
ence of clinical attachment loss (CAL) measurements long term. Presenting the mean differences of clinical attachment loss 
(CAL) in 1 month-45 days, 3 months, 6 months separately and as total after non-surgical periodontal therapy. CAL is measured 
in millimeters (mm).A funnel plot is a graph designed to check for the existence of publication bias.
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ned in patients that presented a susceptible genotype in 
the following genes IL-1, IL-4, IL-8, MMP-13, MMP-1 
and MBL.
- Other systematic review
So far a systematic review was conducted in 2007 (50) 
which investigated the influence of the composite ge-
notype in periodontitis progression and periodontal 
treatment outcome. This study compared only IL-1 di-
fferent genotypes (presence of the allele 2 in the gene 
clusters IL-1A -889 and in IL-1B +3953). The heteroge-
neity of the study design, the periodontal status and the 
treatment plan of the included studies did not allow a 
meta-analysis to be done. The eleven included publica-
tions of the systematic review of 2007 led to the conclu-
sion that there is inadequate evidence to determine an 
association among IL-1 positive genotype progression 
and treatment of periodontal disease outcomes. 
- Site-based, tooth-based or subject based analysis
All the included studies used site-based and subject-
based analyses of the clinical measurements. Although 
clinically it is more beneficial to conduct site-based and 
tooth-based analyses than subject-based, it is not co-
rrect to treat sites and teeth individually. Each site or 
teeth share the same conditions and risk factors.
A result of the differences between the site-based and 
the patient-based analyses is depicted in the levels of 
the periodontopathogens in the study of Finoti et al. 
(43). In the site-based analysis a significant association 
Fig. 4. The forest plot and the funnel plot of the comparison: long term effects of each study and PI (%).
Meta-analysis and forest plot comparing susceptible (SCP) and non-susceptible (NSCP) to periodontal disease with the differ-
ence of plaque score (PI) long term. Presenting the mean differences of plaque index (PI) after non-surgical periodontal therapy 
in 1 month-45 days, 3 months, 6 months separately and as total. PI is measured in percentage. The funnel plot is designed to 
check for the existence of publication bias. Publications regarding PI found to have higher asymmetry than BOP and CAL but 
less asymmetry than PPD.
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between the susceptible group of patients compared to 
the other non-susceptible group was concluded. On the 
other hand, the multilevel logistic regression analysis, 
which is a patient-based analysis, did not report any sta-
tistically significant difference.
Functionality of gene polymorphisms at a protein level
Gene mutations can have significant, minimal or no 
phenotypic effect. Functional mutations can lead to 
changes in the structure of an encoded protein, or to 
a decrease, to or complete loss in its expression. For 
example, gene mutation can result in a substitution of a 
different aminoacid into the polypeptide sequence, or in 
the formation of a stop codon, which is going to give a 
truncated protein with little or no function. On the other 
hand, silent mutations result in the same aminoacid se-
quence of the original protein and as a result have no 
effect on the function of the protein. 
From the papers included in the study, it is know that 
the mutations in the IL-8 gene are functional (43,46). 
Specifically, there is evidence that carriers of the single 
                    
            
Fig.  5. The forest plot and the funnel plot of the comparison: long term effects of each study and PPD (mm).
Meta-analysis and forest plot comparing susceptible (SCP) and non-susceptible (NSCP) to periodontal disease with the differ-
ence of probing pocket depth (PPD) measurements long term. Presenting the mean differences of probing pocket depth (PPD) 
in 1 month-45 days, 3 months, 6 months separately and as total after non-surgical periodontal therapy. PPD is measured in 
millimeters (mm). The funnel plot is designed to check for the existence of publication bias. Publications regarding PPD found 
to have more asymmetry than the other clinical parameters.
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nucleotide substitution -251 (T/A) express higher levels 
of IL-8 in whole blood stimulated with E. Coli lipopo-
lysaccharide (LPS) than individuals with the wild type 
allele (51). Moreover, an indication that the AGT/TTC 
mutation is functional, is the fact that patients carrying 
this mutated IL-8 allele harbor higher levels of red com-
plex bacteria compared to diseased sites of ATC/TTC 
(43).
Moreover, for the mutations in exon 1 of MBL gene in 
the paper by Ozcaka et al. (22), there is evidence that 
they are functional, since they result in functional de-
ficiency of the protein due to impaired oligomerization 
(52,53).
MMPs are enzymes that degrade proteins of the connec-
tive tissue and basements membranes and in periodon-
tal disease play an important role in tissue destruction. 
It is interesting that the activity of MMPs is not regu-
lated only in transcriptional level. All MMPs exist in a 
latent and active form. Disruption of a Cys-Zn2 bond, 
caused by chemical or physical means, results in a con-
formational change of the protein (54). This new ‘open’ 
conformation of the protein is active (54). MMP activity 
is regulated at a different level too. Tissue inhibitors of 
metalloproteinases (TIMPs) are enzymes that form non-
covalent bimolecular complexes with the active forms of 
MMPs. TIMPS inhibit the activity of the fully compe-
tent MMP, but they can also delay or inhibit activation of 
the MMP proenzyme (55,56). In the studies by Pirhan et 
al. (44,45), the mutant allele formed by a G insertion at 
the polymorphic site of MMP-1 promoter binds more re-
combinant Ets-1 transcription factor and has significantly 
higher transcriptional activities compared to the wild 
type allele, which indicates that this insertion mutation 
is fully functional (57). As mentioned above, the increa-
sed transcriptional activity does not necessarily mean an 
increased destructive activity in connective tissue and 
basement membranes (44,45).
As far as the IL-4 studied polymorphism by Anovazzi et 
al. (41) and Finoti et al. (42) it was shown in a previous 
study that Th cells homozygous for the polymorphic alle-
le produce lower levels of IL-4 (58). It is interesting also 
that the three mutations in the IL-4 gene are in linkage 
disequilibrium with each other and this is the reason why 
they are usually inherited all three of them together.
Yoshie et al. (48) studied the salivary enzyme levels af-
ter scaling and root planing in association with the IL-1 
genotypes. The IL-1 polymorphism included in this re-
search are functional, since in a previous study it was 
shown that carriers of the mutated allele were associa-
ted with a four-fold increase in IL-1a protein in gingival 
crevicular fluid (GCF) compared to healthy individuals 
(59).
The only study that does not provide evidence that the 
studied polymorphism is functional is the paper by 
D’Auito et al. (47) regarding the IL-6 polymorphism 
and its effect on periodontal treatment results. Overall, 
there is strong evidence that all the polymorphisms in-
cluded in this meta-analysis have a significant effect at 
protein level.
- Limitations and future studies
One of the main limitations of the included studies was 
the number of patients. The study populations were cha-
racterized as small with different smoking habits. In the 
study of Finoti et al. (42), fifteen patients were enrolled 
and only six of them were susceptible to periodontal 
disease. Anovazzi et al. (41) also in another study in-
cluded 26 subjects diagnosed with chronic periodonti-
tis and 16 of them were IL-4 positive genotyped. The 
sample of the studies may thus affect in the reliability of 
the results. The results of the present meta-analysis give 
some indications of the influence of several gene po-
lymorphism on the non-surgical periodontal treatment. 
The small sample size in some included studies as well 
as the limited studied gene polymorphisms help in un-
derstanding the tendency of such studies. 
Furthermore, the calculated estimations of the CIs of 
the difference for each time interval are totally based 
on the assumption that the correlation between the two 
measures is 0.5, given that the studies did not report 
such information. Thusly, current results should be used 
with consideration.
Future studies should investigate the influence of di-
fferent genetic polymorphisms of a variety of genes on 
several periodontal diseases and their association with 
the response of the non-surgical periodontal treatment. 
Genetics play a complex role in multifactorial diseases 
such as periodontal disease (60). It is possible that ethni-
cities and races are affected by different bacterial stra-
ins. The bacterial biofilm composition in combination 
with a certain susceptible genotype might affect the pe-
riodontal treatment outcome in certain populations.  For 
example, it is known that A. actinomycetemcomitans 
serotypes vary among different ethnicities and geogra-
phic populations (61). This bacterial strain in a suscepti-
ble genotype background might change the periodontal 
treatment outcome.  
There is a lot of evidence regarding the genetic sus-
ceptibility to periodontal diseases. The rejection of the 
hypothesis of this systematic review might be due to the 
multifactorial etiology of periodontal diseases. Predis-
posing factors such as cardiovascular diseases, rheuma-
toid arthritis and diabetes mellitus are possible causes 
of the absence of statistically significant differences 
between the susceptible and non-susceptible subjects to 
periodontal disease. 
Genomic testing has fueled expectations for more effec-
tive prevention, earlier diagnosis, better prognosis and 
guide for the best individualized treatment protocol. 
Genetic testing has also promised a more successful 
treatment outcome for patients (62). The expectations 
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became higher when the personalized dentistry presen-
ted to be the future of dentistry (63). Susceptible geno-
types of periodontitis may have an important role in the 
onset and progression of periodontal disease, but their 
influence in non-surgical periodontal treatment outco-
me is non-significant.
The results of this meta-analysis indicate that more me-
thodologically sound studies are necessary in the future 
to be conducted in order to obtain more reliable results. 
More studies in different ethnicities and races and in 
patients with systematic diseases that are associated 
with periodontal diseases are needed.
The Quality in Prognostic studies (QUIPS) tool was utilized to identify biases in the included studies. For the evaluation of the validity 
and bias of the studies, six domains were considered: study participation, study attrition, prognostic factor measurement, confounding 
measurement, outcome measurement, statistical analysis and reporting are included in this scale. The vast majority of the included 
publications exhibited low risk of bias, validating the results of the Newcastle-Ottawa scale regarding the high methodological quality 
of the studies.
Author, Year of 
publication,
Reference 
Study 
participation 
Study 
Attrition
Prognostic
Factor
Measurement 
Outcome
Measurement 
Study 
Confounding 
Statistical
Analysis and 
Reporting
Corbi et al. 2013,  
(46) Low Low Low Low Low Low 
Pirhan et al. 2009, 
(45) Low Moderate Low Low Low Low 
Pirhan et al. 2008, 
(44) Low Moderate Low Low Low Low 
Yoshie et al. 2007, 
(48) Moderate Low Low Low Low Low 
Anovazzi et al. 2013, 
(41) Low Low Low Low Low Low 
Finoti et al. 2013, 
(43) Low Low Low Low Low Low 
Finoti et al. 2013, 
(42) Low Low Low Low Low Low 
Ozcaka et al. 2010, 
(22) Low Low Low Low Low Low 
D'Aiuto et al. 2005, 
(47) Low Low Low Low Low Moderate 
Table 5. Quality in Prognostic Studies (QUIPS) tool.
- Design of the studies-Quality assessment and risk of bias
All the included studies are prospective cohorts. In such 
studies the exposure has already occurred, and the aim 
of these studies is to examine the outcome. The risk 
factors are determined in the beginning of the study, 
whereas the outcome will be recorded at a future time 
during the follow up. In prospective cohort studies, the 
selection bias of the population is not expected to be 
present. Unfortunately, the retention of subjects may 
bias the results. Cohort members may refuse to conti-
nue to participate in the study, which may lead to over-
estimation or underestimation of the study results. The 
included studies were assessed by the NOS (Table 1), 
revealing that all the included studies were of high me-
thodological quality and the risk of bias was low (Table 
4). The Quality in Prognostic studies (QUIPS) tool was 
also utilized to identify biases in the included studies 
(64). For the evaluation of the validity and bias of the 
studies, six domains were considered: study participa-
tion, study attrition, prognostic factor measurement, 
confounding measurement, outcome measurement, sta-
tistical analysis and reporting (64). The vast majority 
of the included publications exhibited low risk of bias 
for all the above criteria (Table 5), validating the results 
of the Newcastle-Ottawa scale regarding the high me-
thodological quality of the studies.
Conclusion
Within the limitations of this review, we conclude that 
the clinical outcome of the three examined parameters 
(BOP, CAL and PI) following non-surgical periodontal 
therapy has no difference regarding the genotype sta-
tus of the patient. PPD measurements in the first three 
months and in long-term results found to have a signifi-
cant difference with the baseline records. The existing 
literature does not allow us to reach a clear conclusion 
as far as the influence of smoking habits on the clinical 
outcomes after non-surgical periodontal therapy in sus-
ceptible individuals to periodontitis. More publications 
with focused questions are needed to identify a cause-
effect relationship.
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